Zhejiang Shengda Pharm (603079) - Total Liabilities

Latest as of March 2026: CN¥561.97 Million CNY ≈ $82.23 Million USD

Based on the latest financial reports, Zhejiang Shengda Pharm (603079) has total liabilities worth CN¥561.97 Million CNY (≈ $82.23 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603079 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Zhejiang Shengda Pharm - Total Liabilities Trend (2012–2025)

This chart illustrates how Zhejiang Shengda Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 603079 total asset value.

Zhejiang Shengda Pharm Competitors by Total Liabilities

The table below lists competitors of Zhejiang Shengda Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Bsm Chemical Co Ltd SHE:300796	China	CN¥1.50 Billion
Qingdao Foods Co Ltd SHE:001219	China	CN¥152.00 Million
Long Yuan Construction Group Co Ltd SHG:600491	China	CN¥40.19 Billion
Solus Advanced Materials Co Ltd KO:336370	Korea	₩1.08 Trillion
AVI Japan Opportunity Trust PLC LSE:AJOT	UK	£36.76 Million
Bigcommerce Holdings Inc NASDAQ:BIGC	USA	$263.77 Million
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited F:GU5	Germany	€47.87 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Zhejiang Shengda Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 603079 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.69	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Shengda Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Shengda Pharm (2012–2025)

The table below shows the annual total liabilities of Zhejiang Shengda Pharm from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥583.75 Million ≈ $85.42 Million	+16.44%
2024-12-31	CN¥501.34 Million ≈ $73.36 Million	+11.61%
2023-12-31	CN¥449.20 Million ≈ $65.73 Million	+44.08%
2022-12-31	CN¥311.76 Million ≈ $45.62 Million	-27.13%
2021-12-31	CN¥427.84 Million ≈ $62.61 Million	+13.85%
2020-12-31	CN¥375.80 Million ≈ $54.99 Million	-39.47%
2019-12-31	CN¥620.88 Million ≈ $90.85 Million	+46.33%
2018-12-31	CN¥424.29 Million ≈ $62.09 Million	+95.28%
2017-12-31	CN¥217.27 Million ≈ $31.79 Million	-27.90%
2016-12-31	CN¥301.35 Million ≈ $44.10 Million	+62.85%
2015-12-31	CN¥185.05 Million ≈ $27.08 Million	-17.17%
2014-12-31	CN¥223.40 Million ≈ $32.69 Million	-0.27%
2013-12-31	CN¥224.00 Million ≈ $32.78 Million	-30.31%
2012-12-31	CN¥321.43 Million ≈ $47.04 Million	--

About Zhejiang Shengda Pharm

SHG:603079 China Drug Manufacturers - Specialty & Generic

Market Cap

$362.64 Million

CN¥2.48 Billion CNY

Market Cap Rank

#14037 Global

#4230 in China

Share Price

CN¥13.11

Change (1 day)

-1.28%

52-Week Range

CN¥10.04 - CN¥21.99

All Time High

CN¥53.01